duvakitug
Generic: anti-TL1A
duvakitug: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) | Phase 3 |
Get deeper analysis on duvakitug
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis